INBS
Income statement / Annual
Last year (2024), Intelligent Bio Solutions Inc.'s total revenue was $3.11 M,
an increase of 147.58% from the previous year.
In 2024, Intelligent Bio Solutions Inc.'s net income was -$10.16 M.
See Intelligent Bio Solutions Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
| Operating Revenue |
$3.11 M
|
$1.26 M
|
$0.00
|
$1.98 M
|
$188,744.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$1.69 M |
$930,204.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$1.43 M |
$326,668.00 |
$0.00 |
$1.98 M |
$188,744.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0.46 |
0.26 |
0 |
1 |
1 |
0 |
0 |
0 |
| Research and Development
Expenses |
$1.67 M
|
$507,424.00
|
$3.85 M
|
$4.27 M
|
$588,206.00
|
$3.18 M
|
$2.53 M
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$4.92 M
|
$3.71 M
|
$2.43 M
|
$3.55 M
|
$2.08 M
|
$139,095.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$33,902.00
|
| Selling, General &
Administrative Expenses |
$9.26 M
|
$8.03 M
|
$4.92 M
|
$3.71 M
|
$2.43 M
|
$3.55 M
|
$2.08 M
|
$172,997.00
|
| Other Expenses |
$776,498.00 |
$0.00 |
-$437,146.00 |
-$947,409.00 |
-$188,744.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$11.71 M |
$8.76 M |
$8.34 M |
$7.03 M |
$2.83 M |
$6.73 M |
$4.60 M |
$172,997.00 |
| Cost And Expenses |
$13.39 M |
$9.69 M |
$8.34 M |
$7.03 M |
$2.83 M |
$6.73 M |
$4.60 M |
$172,997.00 |
| Interest Income |
$84,822.00 |
$9,676.00 |
$14,426.00 |
$13,806.00 |
$97.00 |
$188.00 |
$564.00 |
$151,282.00 |
| Interest Expense |
$167,140.00 |
$223,534.00 |
$7,539.00 |
$1.09 M |
$457,745.00 |
$664,840.00 |
$453,872.00 |
$0.00 |
| Depreciation &
Amortization |
$1.21 M
|
$966,732.00
|
$8.34 M
|
$5.21 M
|
$2.60 M
|
$5.83 M
|
$4.60 M
|
$188,724.00
|
| EBITDA |
-$8.99 M
|
-$7.46 M
|
-$8.32 M
|
-$7.15 M
|
-$2.71 M
|
-$6.73 M
|
-$4.60 M
|
-$151,282.00
|
| EBITDA Ratio |
-2.89 |
-5.94 |
0 |
-3.61 |
-14.34 |
0 |
0 |
0 |
| Operating Income Ratio
|
-3.3
|
-10.02
|
0
|
-2.81
|
-14.34
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$174,560.00
|
-$2.01 M
|
$2,900.00
|
-$2.95 M
|
-$457,745.00
|
-$664,840.00
|
-$453,308.00
|
-$138,672.00
|
| Income Before Tax |
-$10.19 M |
-$10.66 M |
-$8.33 M |
-$8.52 M |
-$3.16 M |
-$7.39 M |
-$5.06 M |
-$311,672.00 |
| Income Before Tax Ratio
|
-3.27
|
-8.48
|
0
|
-4.3
|
-16.76
|
0
|
0
|
0
|
| Income Tax Expense |
$132,967.00 |
$190,699.00 |
-$27,925.00 |
$2.50 M |
$550,263.00 |
-$57,691.00 |
-$36,392.00 |
-$167,006.00 |
| Net Income |
-$10.16 M |
-$10.63 M |
-$8.31 M |
-$7.04 M |
-$3.16 M |
-$7.34 M |
-$5.02 M |
-$340,006.00 |
| Net Income Ratio |
-3.27 |
-8.46 |
0 |
-3.55 |
-16.76 |
0 |
0 |
0 |
| EPS |
-6.39 |
-10.58 |
-11.33 |
-16.22 |
-8.92 |
-21.01 |
-14.6 |
-0.99 |
| EPS Diluted |
-6.39 |
-10.58 |
-11.33 |
-16.22 |
-8.92 |
-21.01 |
-14.6 |
-0.99 |
| Weighted Average Shares
Out |
$1.59 M
|
$1.00 M
|
$733,263.00
|
$433,950.00
|
$354,600.00
|
$349,280.00
|
$343,750.00
|
$343,750.00
|
| Weighted Average Shares
Out Diluted |
$1.59 M
|
$1.00 M
|
$733,263.00
|
$433,950.00
|
$354,600.00
|
$349,280.00
|
$343,750.00
|
$343,750.00
|
| Link |
|
|
|
|
|
|
|
|
